share_log

Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina

Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina

杰柏思方案公司表示,它被富士制药株式会社所选,以支持在北卡罗来纳州霍利斯普林斯的一家端到端的大规模细胞培养合同制造基地的12亿美元扩建。
Benzinga ·  06/27 07:53

Jacobs Solutions Says It Is Selected By Fujifilm Diosynth Biotechnologies To Support Delivery Of $1.2B Expansion Of An End-to-end, Large-scale Cell Culture Contract Manufacturing Site In Holly Springs, North Carolina

杰柏思方案公司表示,它被富士制药株式会社所选,以支持在北卡罗来纳州霍利斯普林斯的一家端到端的大规模细胞培养合同制造基地的12亿美元扩建。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发